Literature DB >> 8166321

Antiemetic-induced akathisia in cancer patients receiving chemotherapy.

S B Fleishman1, M R Lavin, M Sattler, H Szarka.   

Abstract

A structured, prospective telephone interview was used to assess the prevalence of akathisia in 24 cancer patients receiving metoclopramide or prochlorperazine during or after chemotherapy. Half of the patients reported subjective motor restlessness, and 75% stated that they would not have informed staff. This report suggests that akathisia is frequently unrecognized in chemotherapy patients receiving metoclopramide and prochlorperazine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8166321     DOI: 10.1176/ajp.151.5.763

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  4 in total

1.  Lesson of the week: Akathisia: overlooked at a cost.

Authors:  Hiroko Akagi; T Manoj Kumar
Journal:  BMJ       Date:  2002-06-22

2.  Akathisia causing secondary severe depression in a cancer patient.

Authors:  Takeshi Inoue; Masato Takahashi; Mitsuchika Hosoda; Tsukasa Koyama
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 3.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 4.  Depression and end-of-life care for patients with cancer.

Authors:  Donald L Rosenstein
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.